LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Cyclopentanohydrophenanthrene ring system doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

α-glucosidase inhibitors from lichens

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

&agr;-hydroxyacid esters of DHEA useful against skin disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

(3) and (6) substitued estrogenic compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

(3) and (6) substituted estrogenic compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

(Androst-5-en-17beta -yl)alkyl sulfoxides and sulfones and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

.beta.-(4-isopropenylphenyl)estra-4,9-dienes, their production,

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

.DELTA..sup.4 -19-sulfur substituted-androstene derivatives havi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

.DELTA.5-androstenes useful for promoting weight maintenance or

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

.DELTA.9(11)-dehydro-8-isoestrone used to treat alzheimer's dise

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

.increment..sup.16 unsaturated C.sub.17 heterocyclic steroids us

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

1- or 6-hydroxylated steroids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

1-alkyl-androsta-1,4-diene-3,17-diones their production and phar

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

1-methyl-15.alpha.-(1-oxyalkyl)androsta-1,4-diene-3,17-diones, p

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

1.alpha.,2.alpha.-methylene-6-methylene- and 6.alpha.-methylpreg

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

1.alpha.,7.alpha.-dithio-substituted spirolactones, processes fo

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

10-thioethyl-steroids

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11 .beta.-(4-isopropenylphenyl)estra-4,9-dienes, their productio

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11 .beta.-substituted progesterone analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

11 .beta.-substituted progesterone analogs